MD
Mike Dybbs
Partner at Samsara BioCapital
Burlingame, California
Overview
Mike Dybbs is a Partner at Samsara BioCapital in Burlingame, California, with a PhD from the University of California, Berkeley and an AB from Harvard University. He has served on the Board of Directors for companies like Dimension Therapeutics and Principia Biopharma, and has invested in notable companies such as Nkarta Therapeutics and Sutro Biopharma at various stages of funding rounds.
Work Experience
Partner
2017 - Current
Board of Directors
2015 - 2017
Board of Directors
2014 - 2016
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Raised $337,799,978.00 from Mission BioCapital.
Board of Directors
2012 - 2016
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Raised $40,800,000.00 from Summit Partners, Morningside Group, New Leaf Venture Partners and Kenson Ventures.
Partner
2009 - 2016
New Leaf Venture Partners is a venture capital firm focused on investments in healthcare technology companies.
Board of Directors
2013 - 2014
Principal
2005 - 2009
BCG Securities focuses on wealth management with high net worth individuals.